As of January 22, 2025, Foghorn Therapeutics (FHTX) has a market cap of $0.24 billion USD. According to our data, Foghorn Therapeutics is ranked No.6910 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.24 B |
-7.42%
|
Dec 31, 2024 | $0.26 B |
-26.82%
|
Dec 29, 2023 | $0.36 B |
1.10%
|
Dec 30, 2022 | $0.35 B |
-72.10%
|
Dec 31, 2021 | $1.27 B |
12.83%
|
Dec 31, 2020 | $1.13 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Sage Therapeutics
SAGE
|
$0.43 B |
-0.000 M
|
USA
|
Relay Therapeutics
RLAY
|
$0.82 B |
0.000 M
|
USA
|
Blueprint Medicines
BPMC
|
$7.06 B |
-0.000 M
|
USA
|
Revolution Medicines
RVMD
|
$7.56 B |
0.000 M
|
USA
|
Kura Oncology
KURA
|
$0.61 B |
0.000 M
|
USA
|
Zentalis Pharmaceuticals
ZNTL
|
$0.16 B |
0.000 M
|
USA
|
IDEAYA Biosciences
IDYA
|
$2.00 B |
-0.000 M
|
USA
|
G1 Therapeutics
GTHX
|
$0.38 B |
0.000 M
|
USA
|
Syros Pharmaceuticals
SYRS
|
$5.51 M |
0.000 M
|
USA
|
Deciphera Pharmaceuticals
DCPH
|
$2.21 B |
2.213 B
|
USA
|
Market Cap | = | FHTX Stock Price | * | FHTX Shares Outstanding |
= | $4.37 | * | 55.59 M | |
= | $0.24 B |